Company Filing History:
Years Active: 2011-2021
Title: Innovations by Stephen P Wanaski
Introduction
Stephen P Wanaski is an accomplished inventor based in Chicago, IL. He has made significant contributions to the field of pharmaceuticals, particularly in therapies for serious medical conditions. With a total of 2 patents, his work focuses on innovative methods to improve patient care and treatment outcomes.
Latest Patents
Wanaski's latest patents include groundbreaking methods of administering deflazacort therapy. This therapy is designed for subjects suffering from Duchenne muscular dystrophy (DMD) and involves administering a fixed dose of deflazacort. The patent also outlines strategies for adjusting the dosage based on the patient's condition, such as increasing the dosage when the subject loses ambulation or during the administration of CYP3A inducers or inhibitors.
Another notable patent involves pharmaceutical compositions and methods of use for lipophilic, silicon-substituted, cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs. This innovation describes novel compositions that aim to treat, prevent, and reduce inflammation, pain, and various diseases, including Alzheimer's disease and cancer. The methods are effective in minimizing the toxicities associated with traditional non-steroidal anti-inflammatory drugs.
Career Highlights
Throughout his career, Wanaski has worked with reputable companies such as Silamed, Inc. and PTC Therapeutics, Inc. His experience in these organizations has contributed to his expertise in pharmaceutical development and innovation.
Collaborations
Wanaski has collaborated with notable professionals in his field, including Stephen Gately and Virginia D Schmith. These partnerships have likely enhanced his research and development efforts.
Conclusion
Stephen P Wanaski's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through inventive solutions. His patents reflect a deep understanding of complex medical challenges and a dedication to advancing treatment methodologies.